Ikarian Capital »

Mind Medicine Mindmed shares owned by Ikarian Capital

Quarter-by-quarter ownership of Mind Medicine Mindmed (MNMD) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Mind Medicine Mindmed

Tip: Access up to 7 years of quarterly data

All positions including Mind Medicine Mindmed held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mind Medicine Mindmed by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $356k 63k 5.69
2024-06-30 $1.2M 163k 7.21
2024-03-31 $2.8M 298k 9.40
2023-12-31 $2.2M 600k 3.66

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Mind Medicine Mindmed

Commodore Capital
Deep Track Capital
BlackRock
BlackRock
Blackstone Group
Driehaus Capital Management
Octagon Capital Advisors
Marshall Wace
State Street Corporation
Vanguard Group
Geode Capital Management
Woodline Partners
AWM Investment Company
Two Sigma Investments
Northern Trust

View all funds holding Mind Medicine Mindmed